Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Gemcitabine/Carboplatin and Concurrent Chemoradiation in Stage IIIA/IIIB NSCLC
NCT00226590Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Apr 2003
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Moffitt Cancer Center. Started Apr 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00226590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226590.